Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model

K. B. Reddy, R. McGowen, L. Schuger, Daniel W Visscher, S. Sheng

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Maspin is a novel serine protease inhibitor (serpin) with tumor suppressive activity. To date, despite the mounting evidence implicating the potential diagnostic/prognostic and therapeutic value of maspin in breast and prostate carcinoma, the lack of a suitable animal model hampers the in vivo investigation on the role of maspin at different stages of tumor progression. In this study, we used MMTV/TGF-α transgenic mouse model to study the expression profile of maspin in mammary tumor progression. Histopathological examinations of MMTV/TGF-α transgenic mice revealed TGF-α expression leading to hyperproliferation, hyperplasia, and occasional carcinoma in mammary gland. Interestingly, when MMTV/TGF-α transgenic mice were breed to homozygocity, they also developed characteristic skin papillomas. Immunohistochemistry analysis of maspin expression in the breast tissues of TGF-α transgenic mice showed a direct correlation between down-regulation of maspin expression and tumor progression. The loss of maspin expression was concomitant with the critical transition from carcinoma in situ to invasive carcinoma. Subsequent in-situ hybridization analyses suggest that the down-regulation of maspin expression is primarily a transcriptional event. This data is consistent with the tumor suppressive role of maspin. Furthermore, our data suggests that MMTV/TGF-α transgenic mouse model is advantageous for in vivo evaluation of both the expression and the biological function of maspin during the slow multi-stage carcinogenesis of mammary gland.

Original languageEnglish (US)
Pages (from-to)6538-6543
Number of pages6
JournalOncogene
Volume20
Issue number45
DOIs
StatePublished - Oct 4 2001
Externally publishedYes

Fingerprint

Transforming Growth Factor alpha
Transgenic Mice
Breast Neoplasms
Human Mammary Glands
Neoplasms
Down-Regulation
SERPIN-B5
Carcinoma
Serine Proteinase Inhibitors
Carcinoma in Situ
Papilloma
Hyperplasia
In Situ Hybridization
Prostate
Carcinogenesis
Breast
Animal Models
Immunohistochemistry
Skin

Keywords

  • Carcinoma in situ
  • Hyperplasia
  • Immunohistochemistry
  • In situ hybridization
  • Invasive carcinoma

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model. / Reddy, K. B.; McGowen, R.; Schuger, L.; Visscher, Daniel W; Sheng, S.

In: Oncogene, Vol. 20, No. 45, 04.10.2001, p. 6538-6543.

Research output: Contribution to journalArticle

Reddy, K. B. ; McGowen, R. ; Schuger, L. ; Visscher, Daniel W ; Sheng, S. / Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model. In: Oncogene. 2001 ; Vol. 20, No. 45. pp. 6538-6543.
@article{ddb290504bea48d6bcbd768b088127d2,
title = "Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model",
abstract = "Maspin is a novel serine protease inhibitor (serpin) with tumor suppressive activity. To date, despite the mounting evidence implicating the potential diagnostic/prognostic and therapeutic value of maspin in breast and prostate carcinoma, the lack of a suitable animal model hampers the in vivo investigation on the role of maspin at different stages of tumor progression. In this study, we used MMTV/TGF-α transgenic mouse model to study the expression profile of maspin in mammary tumor progression. Histopathological examinations of MMTV/TGF-α transgenic mice revealed TGF-α expression leading to hyperproliferation, hyperplasia, and occasional carcinoma in mammary gland. Interestingly, when MMTV/TGF-α transgenic mice were breed to homozygocity, they also developed characteristic skin papillomas. Immunohistochemistry analysis of maspin expression in the breast tissues of TGF-α transgenic mice showed a direct correlation between down-regulation of maspin expression and tumor progression. The loss of maspin expression was concomitant with the critical transition from carcinoma in situ to invasive carcinoma. Subsequent in-situ hybridization analyses suggest that the down-regulation of maspin expression is primarily a transcriptional event. This data is consistent with the tumor suppressive role of maspin. Furthermore, our data suggests that MMTV/TGF-α transgenic mouse model is advantageous for in vivo evaluation of both the expression and the biological function of maspin during the slow multi-stage carcinogenesis of mammary gland.",
keywords = "Carcinoma in situ, Hyperplasia, Immunohistochemistry, In situ hybridization, Invasive carcinoma",
author = "Reddy, {K. B.} and R. McGowen and L. Schuger and Visscher, {Daniel W} and S. Sheng",
year = "2001",
month = "10",
day = "4",
doi = "10.1038/sj.onc.1204796",
language = "English (US)",
volume = "20",
pages = "6538--6543",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "45",

}

TY - JOUR

T1 - Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model

AU - Reddy, K. B.

AU - McGowen, R.

AU - Schuger, L.

AU - Visscher, Daniel W

AU - Sheng, S.

PY - 2001/10/4

Y1 - 2001/10/4

N2 - Maspin is a novel serine protease inhibitor (serpin) with tumor suppressive activity. To date, despite the mounting evidence implicating the potential diagnostic/prognostic and therapeutic value of maspin in breast and prostate carcinoma, the lack of a suitable animal model hampers the in vivo investigation on the role of maspin at different stages of tumor progression. In this study, we used MMTV/TGF-α transgenic mouse model to study the expression profile of maspin in mammary tumor progression. Histopathological examinations of MMTV/TGF-α transgenic mice revealed TGF-α expression leading to hyperproliferation, hyperplasia, and occasional carcinoma in mammary gland. Interestingly, when MMTV/TGF-α transgenic mice were breed to homozygocity, they also developed characteristic skin papillomas. Immunohistochemistry analysis of maspin expression in the breast tissues of TGF-α transgenic mice showed a direct correlation between down-regulation of maspin expression and tumor progression. The loss of maspin expression was concomitant with the critical transition from carcinoma in situ to invasive carcinoma. Subsequent in-situ hybridization analyses suggest that the down-regulation of maspin expression is primarily a transcriptional event. This data is consistent with the tumor suppressive role of maspin. Furthermore, our data suggests that MMTV/TGF-α transgenic mouse model is advantageous for in vivo evaluation of both the expression and the biological function of maspin during the slow multi-stage carcinogenesis of mammary gland.

AB - Maspin is a novel serine protease inhibitor (serpin) with tumor suppressive activity. To date, despite the mounting evidence implicating the potential diagnostic/prognostic and therapeutic value of maspin in breast and prostate carcinoma, the lack of a suitable animal model hampers the in vivo investigation on the role of maspin at different stages of tumor progression. In this study, we used MMTV/TGF-α transgenic mouse model to study the expression profile of maspin in mammary tumor progression. Histopathological examinations of MMTV/TGF-α transgenic mice revealed TGF-α expression leading to hyperproliferation, hyperplasia, and occasional carcinoma in mammary gland. Interestingly, when MMTV/TGF-α transgenic mice were breed to homozygocity, they also developed characteristic skin papillomas. Immunohistochemistry analysis of maspin expression in the breast tissues of TGF-α transgenic mice showed a direct correlation between down-regulation of maspin expression and tumor progression. The loss of maspin expression was concomitant with the critical transition from carcinoma in situ to invasive carcinoma. Subsequent in-situ hybridization analyses suggest that the down-regulation of maspin expression is primarily a transcriptional event. This data is consistent with the tumor suppressive role of maspin. Furthermore, our data suggests that MMTV/TGF-α transgenic mouse model is advantageous for in vivo evaluation of both the expression and the biological function of maspin during the slow multi-stage carcinogenesis of mammary gland.

KW - Carcinoma in situ

KW - Hyperplasia

KW - Immunohistochemistry

KW - In situ hybridization

KW - Invasive carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0035807287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035807287&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1204796

DO - 10.1038/sj.onc.1204796

M3 - Article

VL - 20

SP - 6538

EP - 6543

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 45

ER -